GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (NAS:FBLG) » Definitions » Pre-Tax Income

FibroBiologics (FibroBiologics) Pre-Tax Income : $-22.53 Mil (TTM As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. FibroBiologics's pretax income for the three months ended in Mar. 2024 was $-8.46 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was $-22.53 Mil. FibroBiologics's pretax margin was %.


FibroBiologics Pre-Tax Income Historical Data

The historical data trend for FibroBiologics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics Pre-Tax Income Chart

FibroBiologics Annual Data
Trend Dec21 Dec22 Dec23
Pre-Tax Income
-1.58 -5.12 -16.49

FibroBiologics Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only -2.42 -2.16 -2.19 -9.72 -8.46

Competitive Comparison of FibroBiologics's Pre-Tax Income

For the Biotechnology subindustry, FibroBiologics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


FibroBiologics's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FibroBiologics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where FibroBiologics's Pre-Tax Income falls into.



FibroBiologics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

FibroBiologics's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-8.889+-7.449+-0.147+0+0
=-16.49

FibroBiologics's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-3.45+-5.045+-0.004+0.039+0
=-8.46

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-22.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


FibroBiologics  (NAS:FBLG) Pre-Tax Income Explanation

FibroBiologics's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-8.46/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


FibroBiologics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of FibroBiologics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


FibroBiologics (FibroBiologics) Business Description

Comparable Companies
Traded in Other Exchanges
Address
455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598
FibroBiologics Inc is an early-stage, cell therapy company. Its primary focus is the initiation and progression of preclinical studies and clinical-stage FDA trials related to fibroblast treatments for Degenerative Disc Disease, Multiple Sclerosis, Cancer, Wound Healing, and other diseases.

FibroBiologics (FibroBiologics) Headlines